✦ LIBER ✦

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

✍ Scribed by Arijs, I.; Li, K.; Toedter, G.; Quintens, R.; Van Lommel, L.; Van Steen, K.; Leemans, P.; De Hertogh, G.; Lemaire, K.; Ferrante, M.; Schnitzler, F.; Thorrez, L.; Ma, K.; Song, X.-Y. R.; Marano, C.; Van Assche, G.; Vermeire, S.; Geboes, K.; Schuit, F.; Baribaud, F.; Rutgeerts, P.

Book ID: 124160029
Publisher: BMJ Publishing Group
Year: 2009
Tongue: English
Weight: 356 KB
Volume: 58
Category: Article
ISSN: 0017-5749
DOI: 10.1136/gut.2009.178665

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mucosal Gene Expression Signatures That

Mucosal Gene Expression Signatures That Predict Response of Ulcerative Colitis to Infliximab

✍ Alastair J.M. Watson; Mark Tremelling 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 141 KB

822 Mucosal Gene Signatures to Predict R

822 Mucosal Gene Signatures to Predict Response to Infliximab in Patients with Inflammatory Bowel Disease

✍ Ingrid Arijs; Leentje Van Lommel; Kristel Van Steen; Gert De Hertogh; Marc Ferra 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

P200 MUCOSAL GENE SIGNATURES TO PREDICT

P200 MUCOSAL GENE SIGNATURES TO PREDICT RESPONSE TO INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

✍ I. Arijs; L. Van Lommel; K. Van Steen; G. De Hertogh; M. Ferrante; M. Joossens; 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 67 KB

Patients with ulcerative colitis show du

Patients with ulcerative colitis show durable response to infliximab

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Gene Expression Profiling and Response S

Gene Expression Profiling and Response Signatures Associated With Differential Responses to Infliximab Treatment in Ulcerative Colitis

✍ Toedter, Gary; Li, Katherine; Marano, Colleen; Ma, Keying; Sague, Sarah; Huang, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 426 KB

Predictors of early response to inflixim

Predictors of early response to infliximab in patients with ulcerative colitis

✍ Marc Ferrante; Séverine Vermeire; Konstantinos H. Katsanos; Maja Noman; Gert Van 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Background: Our objective is to report the outcome of infliximab (ifx) in ulcerative colitis (uc) patients from a single center and to identify predictors of early clinical response. ## Methods: The first 100 uc patients (45 female; median age, 37.9 years) who received ifx at a single center w